U.S. Court in Delaware Strikes HHS' Violation Letter to AstraZeneca Citing 340B Noncompliance
- February 18, 2022
A federal court in Delaware sided February 14 with AstraZeneca Pharmaceuticals LP in the ongoing dispute between drug companies and the Department of Health and Human Services (HHS) over 340B program requirements.
ARTICLE TAGS
You must be logged in to access this content.